SARILUMAB FOR THE TREATMENT OF ANKYLOSING SPONDYLITIS: RESULTS OF A PHASE 2, RANDOMIZED. DOUBLE-BLIND, PLACEBO-CONTROLLED, INTERNATIONAL STUDY (ALIGN)

Category Primary study
JournalANNALS OF THE RHEUMATIC DISEASES
Year 2013
This article has no abstract
Epistemonikos ID: de241a9232fdcd3432362458646d8f40332a41f4
First added on: Feb 05, 2025